Primary Cilia and Cardiovascular Risk Factors in Alzheimer's Disease
Open accessThe DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index; 37 of the 51 sources its claims cite were checked for support.
Abstract
Alzheimer's disease (AD) is the most common cause of dementia worldwide due to an aging population. AD is characterized as a progressive neurodegenerative disease that leads to atrophy of brain tissue, causing cognitive deficits. Amyloid beta plaques and neurofibrillary tangles are pathological hallmarks of AD, yet the cause is still highly debated. Many other cardiovascular diseases and vascular manifestations share the same symptoms as patients with AD. In this review, the current understanding of AD is summarized with a brief discussion on how primary cilia dysfunction and impaired nitric oxide (NO) signaling contribute to cardiovascular risk factors, vascular pathology, and cognitive decline in AD. Finally, we highlight primary cilia as a possible therapeutic target and any future directions for treating AD.
Overview
CoChat Summary
## TL;DR
This review argues that primary cilia and nitric oxide (NO) signaling may connect cardiovascular risk factors, vascular dysfunction, and cognitive decline in Alzheimer’s disease (AD). It frames AD as involving both neuronal pathology and cerebrovascular/BBB damage, with ciliary dysfunction proposed as a possible therapeutic target.
## Key findings
- The review states that AD is the most common cause of dementia worldwide and notes that about 6.7 million Americans have been diagnosed, with a prevalence of 1 in 9 people aged 65+.
- Primary cilia are described as sensory organelles that detect blood flow and regulate NO release; when cilia fail to sense fluid shear stress, endothelial NO production decreases, which can contribute to hypertension, a reported risk factor for AD.
- In the cilia/Hedgehog section, the paper reports that Aβ deposition shortens cilia in vitro and in vivo, and in mouse NIH3T3 fibroblast cells Aβ caused a significant decrease in primary cilia length and in Shh downstream signaling.
- For vascular disease, the review cites a study of 404 brains showing a strong coincidence/correlation between AD and cerebral amyloid angiopathy (CAA), and multiple biomarker/imaging studies linking BBB disruption with AD.
## Methods
- This is a narrative review of prior literature on AD, primary cilia, NO signaling, cardiovascular risk factors, and vascular pathology.
- The paper synthesizes findings from human studies, animal models, and cell experiments, including studies of 404 brains, three observational European cohorts, four studies in a systematic review, and mouse/NIH3T3 experiments.
- The main approach is conceptual synthesis, not original data analysis; it links reported evidence across ciliary signaling, endothelial dysfunction, BBB leakage, hypertension, diabetes, and amyloid pathology.
## Limitations
- The paper does not report any original sample, cohort, or statistical analysis of its own; this is evident from the text.
- The authors explicitly state that the mechanism of pathology between cilia and AD has not been identified and that further investigations are needed to understand the connection between primary cilia, NO, and AD.
- The text makes evident that much of the evidence is indirect, associative, or preclinical (cell and animal studies), so causal claims remain limited; this is evident from the review’s framing.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 2 Illustration of the structure of primary cilia. The primary cilia are made up of the ciliary membrane, axoneme, and basal body. The ciliary membrane contains protein receptors and channels responsible for proper cilia function. The axoneme forms the ciliary skeleton, while the basal body is anchored to the plasma membrane with the help of the centrioles. Figure is adopted with permission from [50].](https://figures.cochat.ai/paper-figures/d3a52765712943bfafa2fe6e5cc031ad/primary-cilia-and-cardiovascular-risk-factors-in-alzheimer-s-disease-figure-2.jpg)
![Figure 3 Healthy (left) vs. dysfunctional (right) blood brain barrier (BBB). BBB dysfunction may be caused by a disruption in the endothelial cells, leading to decreased tight junction expression and increased vascular permeability. Tight junction protein expression has also been reduced in the presence of Amyloid Beta 42 (Aβ42). Low-density lipoprotein receptor-related protein 2 (LRP2), Glucose Transporter Type 1 (GLUT1), very-low-density-lipoprotein receptor (VLDLR), Permeability Glycoprotein (Pgp), Major facilitator superfamily domain-containing protein 2 (MFSD2a), receptor for advanced glycation end products (RAGE), red blood cell (RBC). Figure is adopted with permission from [102].](https://figures.cochat.ai/paper-figures/7f44746ca65c4bdfa121cbc8f4b6cdb7/primary-cilia-and-cardiovascular-risk-factors-in-alzheimer-s-disease-figure-3.jpg)
![Figure 1 Primary vascular endothelial cilia play a role in the biochemical production of nitric oxide (NO), a potent vasodilator. The figure illustrates how NO is produced in an artery. In physiological conditions, a rise in blood pressure will be detected through the mechanosensory role of primary cilia as a result of increased vascular shear stress. The bending or activation of these cilia involves the mechanosensory polycystin-1 and polycystin-2 complex, triggering a signaling cascade that leads to NO production. This cascade includes an influx of extracellular calcium ions (Ca2+), which subsequently activates several calcium-dependent proteins, such as calmodulin (CaM) and protein kinase C (PKC). Along with protein kinase B (PKB), CaM and PKC act as key downstream effectors that activate endothelial nitric oxide synthase (eNOS), the enzyme responsible for NO synthesis. Figure is adopted with permission from [21].](https://figures.cochat.ai/paper-figures/40eb905bf51640268709dc7f5bb4af51/primary-cilia-and-cardiovascular-risk-factors-in-alzheimer-s-disease-figure-1.jpg)
![Figure 4 NO signaling in healthy vs. Alzheimer’s disease primary cilia. Primary cilia are sensory organelles that extend from the surface of endothelial cells into the blood vessel lumen, where they detect extracellular stimuli and convert them into intracellular biochemical signals, such as NO. In Alzheimer’s Disease Aβ accumulation can possibly disrupt downstream signaling pathways, leading to impaired vascular function and cognitive decline but the exact mechanism is still unclear. Created in part with BioRender Premium [111] (https://help.biorender.com/hc/en-gb/articles/17605447498269-BioRender-Premium accessed on 10 September 2025).](https://figures.cochat.ai/paper-figures/70e54ba812d044f19691afa26ecdda3c/primary-cilia-and-cardiovascular-risk-factors-in-alzheimer-s-disease-figure-4.jpg)
Verification
Claims the paper makes
32 Valid · 0 Not valid · 13 Not checked · 4 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“The shortening of cilia can impair their ability to sense and regulate external signals, leading to the promotion of AD [47].”
§ Primary Cilia and Cardiovascular Risk Factors in Alzheimer’s Disease > 2. Primary Cilia and Ciliary Receptors
What the sources say
- Supportedcites [47] Guo A. Wang H. Zhang Y. Huang H. Changes of the Primary Cilia in Alzheimer’s Disease Pathogenesis Eur. J. Neurosci. 2025 61 e70125 10.1111/ejn.70125 40329506 source
The Discussion states that shortened cilia may impair their ability to sense and regulate external signals, thereby promoting AD progression. The citing sentence paraphrases that qualified claim. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Recently, neuroinflammation, especially through microglial overactivation and the nucleotide-binding domain, leucine-rich–containing family, pyrin domain–containing-3 (NLRP3) inflammasome, has gained recognition as a major driver of neuronal damage in AD, fueling a destructive cycle of reduced amyloid clearance and ongoing degeneration [9].”
§ Primary Cilia and Cardiovascular Risk Factors in Alzheimer’s Disease > 1. Introduction
What the sources say
- Supportedcites [9] Kamila P. Kar K. Chowdhury S. Chakraborty P. Dutta R.S.S. Singh S.A. Prajapati B.G. Effect of neuroinflammation on the progression of Alzheimer’s disease and its significant ramifications for novel anti-inflammatory treatments IBRO Neurosci. Rep. 2025 18 771 782 10.1016/j.ibneur.2025.05.005 40510290 PMC12159511 sourceExperimental — accuracy not yet measured
The Introduction describes chronic neuroinflammation as a key driver of AD, and “Factors facilitating neuroinflammation” links chronic microglial activation to progressive neuronal damage. “Impact of astrocytes, neuroglia, and cell mediators” describes inefficient microglial activation and impaired Aβ clearance, and links NLRP3 activation to further Aβ aggregation and AD progression. The review supports the cited sentence as a synthesis of these mechanisms, rather than stating that NLRP3 itself directly reduces clearance. (LLM, conf=0.86)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In relation to AD, it has been shown that Aβ deposition can cause cilia length to shorten in vitro and in vivo [47,48].”
§ Primary Cilia and Cardiovascular Risk Factors in Alzheimer’s Disease > 2. Primary Cilia and Ciliary Receptors
What the sources say
- Partly supportedcites [47] Guo A. Wang H. Zhang Y. Huang H. Changes of the Primary Cilia in Alzheimer’s Disease Pathogenesis Eur. J. Neurosci. 2025 61 e70125 10.1111/ejn.70125 40329506 sourceExperimental — accuracy not yet measured
Section 3.1 reports that Aβ 1-42 treatment shortened primary cilia in cultured cells and neurons. Section 3.2 finds shorter neuronal cilia closer to Aβ deposits in AD-model mice, but this in vivo association does not establish that deposition caused the shortening. Page numbers were not available in our copy. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [48] Kobayashi Y. Kohbuchi S. Koganezawa N. Sekino Y. Shirao T. Saido T.C. Saito T. Saito Y. Impairment of ciliary dynamics in an APP knock-in mouse model of Alzheimer’s disease Biochem. Biophys. Res. Commun. 2022 610 85 91 10.1016/j.bbrc.2022.04.050 35453040 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Hypertension in older adults leads to maladaptation of the cerebral circulation, causing a disruption in the blood–brain barrier (BBB) and oxidative stress [86].”
§ Primary Cilia and Cardiovascular Risk Factors in Alzheimer’s Disease > 4. Cardiovascular Risk Factors
What the sources say
- Supportedcites [86] Ungvari Z. Toth P. Tarantini S. Prodan C.I. Sorond F. Merkely B. Csiszar A. Hypertension-induced cognitive impairment: From pathophysiology to public health Nat. Rev. Nephrol. 2021 17 639 654 10.1038/s41581-021-00430-6 34127835 PMC8202227 source
The Age-related maladaptation section says ageing impairs cerebral arteries’ adaptation to hypertension, allowing high pressure to reach vulnerable microvessels. The Adaptation of the cerebral circulation section links this pressure to worsened BBB disruption, while Oxidative stress and cellular resilience links it to increased oxidative stress in older adults. Page numbers are not provided in our copy. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A systematic review of four studies showed a direct association between hypertension and AD neuropathic change [87].”
§ Primary Cilia and Cardiovascular Risk Factors in Alzheimer’s Disease > 4. Cardiovascular Risk Factors
What the sources say
- Partly supportedcites [87] Abdulrahman H. Van Dalen J.W. Den Brok M. Latimer C.S. Larson E.B. Richard E. Hypertension and Alzheimer’s disease pathology at autopsy: A systematic review Alzheimer’s Dement. 2022 18 2308 2326 10.1002/alz.12707 35758526 PMC9796086 sourceExperimental — accuracy not yet measured
The Discussion says four studies reported a direct association between hypertension and AD neuropathological change. However, the Results state that the systematic review included 15 studies, not four, and that findings across studies were inconsistent. Four is the number reporting a direct association, not the number reviewed. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
22 more claims · 13 with their cited sources checked
Create a free account to see all 49 claims and every source verdict.
- Probably not a substantial claim. 8
- It may state two separate claims as one. 19
Citations
Cites
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185 · cited 2×
“Whether it be through passive diffusion, solute carriers, ATP-binding cassette (ABC) transporters, or transcytosis, smaller, highly lipid-soluble, or polar molecules are able to pass through the BBB [101].”
Oxidative Stress: Harms and Benefits for Human Health
Pizzino, G., Irrera, N., Cucinotta, M., Pallio, G., Mannino, F., Arcoraci, V., Squadrito, F., Altavilla, D., & Bitto, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/8416763 · Cited by 4,837 · cited 5×
“But an overload of ROS can lead to the onset or progression of various cancers, diabetes, and atherosclerosis [65].”
InfluentialClinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814 · cited 1×
“It is hypothesized that the AD process begins about 20 years before the clinical onset of dementia [2].”
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Jack, C. R., Andrews, J. S., Beach, T. G., Buracchio, T., Dunn, B., Graf, A., Hansson, O., Ho, C., Jagust, W., McDade, E., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13859 · Cited by 2,803 · cited 2×
“This pattern is being used in the diagnostic criteria of AD as an imaging biomarker in amyloid PET [134,135].”
The Cellular Phase of Alzheimer’s Disease
De Strooper, B., & Karran, E. (2016) · Cell · doi:10.1016/j.cell.2015.12.056 · Cited by 1,990 · cited 2×
“A different model is being developed to look at A β and tau accumulation as part of a cellular phase of AD pathogenesis instead of a sequential pathway [137].”
Masters, C. L., Bateman, R., Blennow, K., Rowe, C. C., Sperling, R. A., & Cummings, J. L. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.56 · Cited by 1,853 · cited 4×
“This pattern is being used in the diagnostic criteria of AD as an imaging biomarker in amyloid PET [134,135].”
InfluentialBlood–brain barrier breakdown is an early biomarker of human cognitive dysfunction
Nation, D. A., Sweeney, M. D., Montagne, A., Sagare, A. P., D’Orazio, L. M., Pachicano, M., Sepehrband, F., Nelson, A. R., Buennagel, D. P., Harrington, M. G., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0297-y · Cited by 1,728 · cited 3×
“One study looked at brain capillary damage using PDGFR β as a CSF biomarker and dynamic contrast-enhanced MRI [121].”
InfluentialGenes and molecular pathways underpinning ciliopathies
Reiter, J. F., & Leroux, M. R. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.60 · Cited by 1,588 · cited 1×
“These diseases, caused by genetic and non-genetic mutations that disrupt primary cilia structure and/or function, include Bardet-Biedl Syndrome, Joubert syndrome, Polycystic kidney disease, some cancers, cardiovascular diseases, osteoarthritis, and neurodegenerative disorders such as AD [128].”
Ownby, R. L., Crocco, E., Acevedo, A., John, V., & Loewenstein, D. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.5.530 · Cited by 1,493 · cited 1×
“Associations have been documented between AD and different disease states, such as gastrointestinal disorders, diabetes, depression, and cardiovascular diseases [16–19].”
Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413 · cited 1×
“In the BBB, the low-density lipoprotein receptor-related protein 1 (LRP1) plays a major role in maintaining A β homeostasis and mediates transport of A β across the BBB into circulation [105,106].”
Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics
Tiwari, S., Atluri, V., Kaushik, A., Yndart, A., & Nair, M. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s200490 · Cited by 1,308 · cited 1×
“A β 42 is more susceptible to aggregation, but aggregation of both can result in blocked ion channels, altered calcium (Ca 2+ ) homeostasis, and decreased energy metabolism and glucose regulation, all of which aid in the deterioration of neuronal health [13].”
G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?
Sriram, K., & Insel, P. A. (2018) · Molecular Pharmacology · doi:10.1124/mol.117.111062 · Cited by 1,258 · cited 1×
“There are a variety of ligand-receptor complexes on the ciliary membrane, one being the GPCRs. GPCRs are the largest family of membrane proteins in the human genome, with over 800 unique members, and are the largest family of targets for approved drugs [57].”
Alzheimer’s disease is type 3 diabetes—Evidence reviewed
de la Monte, S. M., & Wands, J. R. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200619 · Cited by 1,158 · cited 1×
“This association has led AD to be deemed in part a neuroendocrine disorder and given the moniker of “type 3 diabetes” [81].”
Efficacy of acetylcholinesterase inhibitors in Alzheimer’s disease.
Marucci, G., Buccioni, M., Ben, D. D., Lambertucci, C., Volpini, R., & Amenta, F. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108352 · Cited by 1,147 · cited 1×
“Furthermore, the effects of AChEIs on cognition are generally only modest, and AChEIs do not treat the underlying causes of AD or modify the disease in any clinically meaningful way [62].”
Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways
Greenberg, S. M., Bacskai, B. J., Hernandez-Guillamon, M., Pruzin, J., Sperling, R., & van Veluw, S. J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0281-2 · Cited by 947 · cited 2×
“However, AD and CAA do not necessarily manifest in the same way, as CAA is largely caused by blood vessel dysfunction in the form of hemorrhage due to loss of vessel integrity or ischemia caused by the loss of normal blood supply [98].”
Role of Cholinergic Signaling in Alzheimer’s Disease
Chen, Z.-R., Huang, J.-B., Yang, S.-L., & Hong, F.-F. (2022) · Molecules · doi:10.3390/molecules27061816 · Cited by 922 · cited 2×
“AChEIs, including the FDA-approved donepezil, galantamine, and rivastigmine, can relieve cognitive dysfunction and reduce cognitive decline in mild to moderate AD patients [60,61].”
Inducible nitric oxide synthase: Regulation, structure, and inhibition
Cinelli, M. A., Do, H. T., Miley, G. P., & Silverman, R. B. (2020) · Medicinal Research Reviews · doi:10.1002/med.21599 · Cited by 889 · cited 1×
“Pro-inflammatory cytokines and/or bacterial lipopolysaccharides are common culprits [72]. iNOS activity is independent of Ca 2+ and plays an important role in the regulation of neuroinflammation by allowing NO to function as a vasodilator as well as a stimulant in leukocyte adhesion to blood…”
GPCR Dynamics: Structures in Motion
Latorraca, N. R., Venkatakrishnan, A. J., & Dror, R. O. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00177 · Cited by 835 · cited 1×
“GPCRs convert extracellular signals, including neurotransmitters, peptides, ions, odorants, and light, into intracellular effects through conformational changes that allow for the recruitment and activation of a G-protein, inducing a signaling cascade [58].”
Oxidative stress: The core pathogenesis and mechanism of Alzheimer’s disease
Bai, R., Guo, J., Ye, X.-Y., Xie, Y., & Xie, T. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101619 · Cited by 813 · cited 2×
“But when the ROS levels exceed that of the antioxidant activity, they attack cell macromolecules, destroy cell function, and induce neuronal apoptosis [67].”
Oxidative stress in Alzheimer’s disease
Chen, Z., & Zhong, C. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1423-y · Cited by 797 · cited 2×
“The brain is more susceptible to oxidative stress than other organs due to its high energy consumption, and neurons are more likely to be affected by oxidative stress due to their higher metabolic rate [66].”
The blood-brain barrier in Alzheimer’s disease
Zenaro, E., Piacentino, G., & Constantin, G. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.007 · Cited by 767 · cited 1×
“BBB disruption allows peripheral inflammatory mediators and neurotoxic molecules to infiltrate the brain parenchyma, amplifying neuroin-flammation [123,124].”
Mitochondrial Dysfunction and Oxidative Stress in Alzheimer’s Disease
Misrani, A., Tabassum, S., & Yang, L. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.617588 · Cited by 654 · cited 1×
“A new perspective on AD suggests that metabolic dysfunction, mitochondrial dysfunction, and oxidative stress have been identified as early contributors to AD, with amyloid and tau accumulation seen as later outcomes of wider metabolic and vascular disturbances [7].”
Halliday, M. R., Rege, S. V., Ma, Q., Zhao, Z., Miller, C. A., Winkler, E. A., & Zlokovic, B. V. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.44 · Cited by 649 · cited 2×
“Pericytes that are supposed to maintain the integrity of the BBB degenerate in AD [117].”
Primary Cilia and Mammalian Hedgehog Signaling
Bangs, F., & Anderson, K. V. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028175 · Cited by 642 · cited 1×
“The Hh is used frequently for intercellular communication in development, but is entirely dependent on primary cilia [45].”
Lee, S. J. C., Nam, E., Lee, H. J., Savelieff, M. G., & Lim, M. H. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00731g · Cited by 576 · cited 2×
“A β peptides are formed by proteolytic cleavage of the amyloid precursor protein (APP), specifically the hydrophobic transmembrane portion, by β - and γ -secretases [3].”
Hypertension-induced cognitive impairment: From pathophysiology to public health
Ungvari, Z., Toth, P., Tarantini, S., Prodan, C. I., Sorond, F., Merkely, B., & Csiszar, A. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00430-6 · Cited by 544 · cited 3×
“Hypertension is defined by a systolic blood pressure ≥ 140 mmHg or a diastolic blood pressure ≥ 90 mmHg [86].”
InfluentialRAGE, LRP-1, and amyloid-beta protein in Alzheimer’s disease
Donahue, J. E., Flaherty, S. L., Johanson, C. E., Duncan, J. A., Silverberg, G. D., Miller, M. C., Tavares, R., Yang, W., Wu, Q., Sabo, E., et al. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0115-3 · Cited by 519 · cited 1×
“On the opposite side, the receptor for advanced glycation end products (RAGE) mediates the transport of A β from the bloodstream into the brain [108].”
Petrovitch, H., White, L. R., Izmirilian, G., Ross, G. W., Havlik, R. J., Markesbery, W., Nelson, J., Davis, D. G., Hardman, J., Foley, D. J., et al. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00106-8 · Cited by 468
Nitric oxide synthase: expression and expressional control of the three isoforms
F�rstermann, U., & Kleinert, H. (1995) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00172772 · Cited by 466 · cited 1×
“It is most commonly present within endothelial cells, though it has been found in various locations, such as platelets and epithelial kidney cells [74]. eNOS is also constitutively expressed, and its activity is regulated by Ca 2+ [75].”
Motile and non-motile cilia in human pathology: From function to phenotypes
Mitchison, H. M., & Valente, E. M. (2017) · The Journal of Pathology · doi:10.1002/path.4843 · Cited by 448 · cited 2×
“Motile cilia contain dynein motor structures that allow them to move, while non-motile cilia lack these structures [43].”
Alzheimer’s Disease and Vascular Aging
Cortes-Canteli, M., & Iadecola, C. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.10.062 · Cited by 400 · cited 1×
“They represent a component of the BBB that regulates the movement of molecules by transporters and tight junctions, as well as controls vasomotor function by dilation or constriction [92].”
Cerebral amyloid angiopathy pathology and cognitive domains in older persons
Arvanitakis, Z., Leurgans, S. E., Wang, Z., Wilson, R. S., Bennett, D. A., & Schneider, J. A. (2011) · Annals of Neurology · doi:10.1002/ana.22112 · Cited by 383 · cited 1×
“A strong correlation coincidence has been found between AD and CAA in a study of 404 brains [100].”
Clearance of amyloid-β by circulating lipoprotein receptors
Sagare, A., Deane, R., Bell, R. D., Johnson, B., Hamm, K., Pendu, R., Marky, A., Lenting, P. J., Wu, Z., Zarcone, T., et al. (2007) · Nature Medicine · doi:10.1038/nm1635 · Cited by 373 · cited 1×
“Soluble LRP1 (sLRP1) circulates freely in plasma and sequesters free A β in circulation and in neurologically normal people. sLRP1 has been shown to sequester 70–90% of plasm A β [107].”
Convit, A., de Asis, J., de Leon, M. J., Tarshish, C. Y., De Santi, S., & Rusinek, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00107-4 · Cited by 359 · cited 1×
“In the later stages, the disease impacts the medial and inferior temporal lobe, such as the middle temporal gyrus, which regulates semantic memory and language processing, and then later the primary sensory and motor cortex [15].”
Involvement of Lipids in Alzheimer’s Disease Pathology and Potential Therapies
Chew, H., Solomon, V. A., & Fonteh, A. N. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00598 · Cited by 353 · cited 1×
“…the role of the lipid invasion model in AD, which proposes that breakdown of the blood–brain barrier permits harmful lipids like low-density lipoprotein and free fatty acids with inflammatory mediators to enter the brain, thereby triggering and fueling amyloidogenesis and tau pathology [8].”
Cerebral blood flow decrease as an early pathological mechanism in Alzheimer's disease
Korte, N., Nortley, R., & Attwell, D. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02215-w · Cited by 350 · cited 3×
“The reduction in CBF is suggested to start early in preclinical AD, along with a fall in metabolism [96].”
InfluentialThe relationship between Alzheimer's disease and diabetes: Type 3 diabetes?
Kroner, Z. (2009) · PubMed · Cited by 331
Structure–function studies on nitric oxide synthases
LI, H., & POULOS, T. (2005) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2004.10.016 · Cited by 302 · cited 1×
“Within the vast microvascular constructs of the brain, there are two mechanisms in place regulating cerebral blood flow (CBF): autoregulation and neurovascular coupling. nNOS does not work alone, with a multitude of evidence suggesting eNOS also produces NO within the brain [77].”
Fontbonne, A., Berr, C., Ducimetière, P., & Alpérovitch, A. (2001) · Diabetes Care · doi:10.2337/diacare.24.2.366 · Cited by 297 · cited 1×
“A longitudinal study of diabetic patients over a span of 4 years reported a decline in cognitive performance, suggesting a relationship between diabetes and cognition [84].”
Kelleher, R. J., & Soiza, R. L. (2013) · Europe PMC (PubMed Central) · Cited by 277
The Impact of Disease Comorbidities in Alzheimer’s Disease
Santiago, J. A., & Potashkin, J. A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.631770 · Cited by 259 · cited 2×
“One study showed decreased levels of insulin-like growth factor binding protein-2 (IGBP-2) and increased levels of insulin-like growth factor 1 receptor (IGF-1R) in the temporal cortex of AD patients [83].”
Primary cilia in neurodevelopmental disorders
Valente, E. M., Rosti, R. O., Gibbs, E., & Gleeson, J. G. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.247 · Cited by 254 · cited 1×
“Dysregulation of GPCR signaling in cilia has been associated with numerous neurological disorders [59].”
Tonic and phasic nitric oxide signals in hippocampal long-term potentiation
Hopper, R. A., & Garthwaite, J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2259-06.2006 · Cited by 239 · cited 1×
“On the other hand, restoration of endothelial NO signaling has been shown to mitigate these phenotypes across several experimental models [56,115,116], highlighting the therapeutic potential of restoring or enhancing endothelial NO signaling to stabilize the neurovascular unit, reduce amyloid…”
Analysis and modeling of the primary cilium bending response to fluid shear
Schwartz, E. A., Leonard, M. L., Bizios, R., & Bowser, S. S. (1997) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1997.272.1.f132 · Cited by 227
Is Alzheimer’s disease a systemic disease?
Morris, J. K., Honea, R. A., Vidoni, E. D., Swerdlow, R. H., & Burns, J. M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.012 · Cited by 219 · cited 1×
“Increasingly, AD is being reframed as a systemic disorder linked to global aging processes rather than a purely localized brain disease [4,5].”
Combination Drug Therapy for the Management of Alzheimer’s Disease
Kabir, M. T., Uddin, M. S., Mamun, A. A., Jeandet, P., Aleya, L., Mansouri, R. A., Ashraf, G. M., Mathew, B., Bin-Jumah, M. N., & Abdel-Daim, M. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093272 · Cited by 217 · cited 1×
“One of the most studied combination drug therapies is the use of memantine and cholinesterase inhibitors, which has proven clinical efficacy in the treatment of moderate to severe AD [140].”
Blood–Brain Barrier Breakdown in Alzheimer’s Disease: Mechanisms and Targeted Strategies
Alkhalifa, A. E., Al-Ghraiybah, N. F., Odum, J., Shunnarah, J. G., Austin, N., & Kaddoumi, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216288 · Cited by 212
Sonic hedgehog signalling pathway: a complex network
Choudhry, Z., Rikani, A. A., Choudhry, A. M., Tariq, S., Zakaria, F., Asghar, M. W., Sarfraz, M. K., Haider, K., Shafiq, A. A., & Mobassarah, N. J. (2014) · Annals of Neurosciences · doi:10.5214/ans.0972.7531.210109 · Cited by 208 · cited 1×
“The three mammalian Hh proteins are Sonic (Shh), Indian, and Desert, with Shh being the focus with its role as a morphogen and inducing various cell types at different concentration thresholds [46].”
Ramanathan, A., Nelson, A. R., Sagare, A. P., & Zlokovic, B. V. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00136 · Cited by 205 · cited 1×
“In the BBB, the low-density lipoprotein receptor-related protein 1 (LRP1) plays a major role in maintaining A β homeostasis and mediates transport of A β across the BBB into circulation [105,106].”
Niwa, K., Carlson, G. A., & Iadecola, C. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200012000-00005 · Cited by 191 · cited 1×
“A β impairs the capability of cerebral endothelial cells to produce vasodilation, and this impairment is moderated by the production of ROS [109].”
Primary cilia sensitize endothelial cells for fluid shear stress
Hierck, B. P., Van der Heiden, K., Alkemade, F. E., Van de Pas, S., Van Thienen, J. V., Groenendijk, B. C. W., Bax, W. H., Van der Laarse, A., DeRuiter, M. C., Horrevoets, A. J. G., et al. (2008) · Developmental Dynamics · doi:10.1002/dvdy.21472 · Cited by 187
Cilia in the nervous system: linking cilia function and neurodevelopmental disorders
Lee, J. E., & Gleeson, J. G. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283444d05 · Cited by 185
Association between Stroke and Alzheimer's Disease: Systematic Review and Meta-Analysis
Zhou, J., Yu, J.-T., Wang, H.-F., Meng, X.-F., Tan, C.-C., Wang, J., Wang, C., & Tan, L. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140666 · Cited by 184
Lüth, H.-J., Holzer, M., Gärtner, U., Staufenbiel, M., & Arendt, T. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02758-5 · Cited by 183 · cited 1×
“The high levels of NO are thought to be involved in the pathogenesis of AD by possibly directly or indirectly causing neuronal death [79].”
M1 muscarinic acetylcholine receptor in Alzheimer’s disease
Jiang, S., Li, Y., Zhang, C., Zhao, Y., Bu, G., Xu, H., & Zhang, Y. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1406-z · Cited by 175 · cited 2×
“Of all the muscarinic receptors, the muscarinic receptor 3 (M3R) has the lowest expression in the CNS but is highly expressed in the hypothalamus relative to the other subtypes [61,63].”
Masyuk, A. I., Gradilone, S. A., Banales, J. M., Huang, B. Q., Masyuk, T. V., Lee, S.-O., Splinter, P. L., Stroope, A. J., & LaRusso, N. F. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90265.2008 · Cited by 170
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165 · cited 1×
“Increasingly, AD is being reframed as a systemic disorder linked to global aging processes rather than a purely localized brain disease [4,5].”
Endothelial nitric oxide deficiency promotes Alzheimer’s disease pathology
Austin, S. A., Santhanam, A. V., Hinton, D. J., Choi, D., & Katusic, Z. S. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12334 · Cited by 155 · cited 1×
“Since NO is critical for vasodilation, cerebral blood flow regulation, and maintenance of BBB integrity, its deficiency worsens hypoperfusion and promotes additional barrier breakdown [127].”
Poulin, B., Butcher, A., McWilliams, P., Bourgognon, J.-M., Pawlak, R., Kong, K. C., Bottrill, A., Mistry, S., Wess, J., Rosethorne, E. M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914801107 · Cited by 151 · cited 1×
“Compared to many of the other muscarinic receptors, the functions of the M3R in the CNS are unclear [61]; however, phosphorylation of the M3R has been associated with learning and memory [64].”
Primary cilia are required in a unique subpopulation of neural progenitors
Tong, C. K., Han, Y.-G., Shah, J. K., Obernier, K., Guinto, C. D., & Alvarez-Buylla, A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321425111 · Cited by 149
Fu, P., Gao, M., & Yung, K. K. L. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00607 · Cited by 146
The sensory cilium of retinal rods is analogous to the transitional zone of motile cilia
R�hlich, P. (1975) · Cell and Tissue Research · doi:10.1007/bf00220009 · Cited by 145
Dede, D. S., Yavuz, B., Yavuz, B. B., Cankurtaran, M., Halil, M., Ulger, Z., Cankurtaran, E. S., Aytemir, K., Kabakci, G., & Ariogul, S. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01378.x · Cited by 142 · cited 4×
“These correlations between AD and dysfunction of the cerebrovasculature lead to the speculation that AD is a vascular disease [93].”
InfluentialOishi, E., Ohara, T., Sakata, S., Fukuhara, M., Hata, J., Yoshida, D., Shibata, M., Ohtsubo, T., Kitazono, T., Kiyohara, Y., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.025667 · Cited by 140
Park, L., Wang, G., Moore, J., Girouard, H., Zhou, P., Anrather, J., & Iadecola, C. (2014) · Nature Communications · doi:10.1038/ncomms6318 · Cited by 139 · cited 2×
“A β also triggers Ca 2+ increases in endothelial cells by Transient Receptor Potential Cation Channel, Subfamily M, Member 2 (TRPM2) [110].”
Yuan, S., Wang, Z., Peng, H., Ward, S. M., Hennig, G. W., Zheng, H., & Yan, W. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2102940118 · Cited by 137
Type 2 Diabetes and Late-Onset Alzheimer’s Disease
Cheng, D., Noble, J., Tang, M. X., Schupf, N., Mayeux, R., & Luchsinger, J. A. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000324134 · Cited by 134 · cited 1×
“Associations have been documented between AD and different disease states, such as gastrointestinal disorders, diabetes, depression, and cardiovascular diseases [16–19].”
BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis
Zhang, S., Wang, Z., Cai, F., Zhang, M., Wu, Y., Zhang, J., & Song, W. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.0340-17.2017 · Cited by 129 · cited 1×
“APP moderates cell growth, motility, and survival, as well as neurite outgrowth and functions, but in the disease state, APP produces amyloidogenic fragments through differential cleavage by Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE-1) [11,12].”
Blood-brain barrier leakage in Alzheimer’s disease: From discovery to clinical relevance
Nehra, G., Bauer, B., & Hartz, A. M. S. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108119 · Cited by 127 · cited 7×
“Barrier leakage in epilepsy promotes seizures through a positive feedback loop that further progresses the condition [104].”
InfluentialThe role of the immune system in Alzheimer’s disease
Wu, K., Zhang, Y.-R., Huang, Y., Dong, Q., Tan, L., & Yu, J. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101409 · Cited by 127 · cited 1×
“Experimental evidence has demonstrated that immune cells may undergo significant changes and perform different functions at various stages of the disease [10].”
Causes and consequences of baseline cerebral blood flow reductions in Alzheimer’s disease
Bracko, O., Cruz Hernández, J. C., Park, L., Nishimura, N., & Schaffer, C. B. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20982383 · Cited by 124 · cited 5×
“These changes can be correlated with increased levels of ROS, but these changes can be more severe in AD patients [95].”
InfluentialChen, Y., He, Y., Han, J., Wei, W., & Chen, F. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1258640 · Cited by 116 · cited 2×
“Pericytes make up part of the basement membrane and regulate vascular permeability [103].”
Primary cilia and ciliary signaling pathways in aging and age-related brain disorders
Ma, R., Kutchy, N. A., Chen, L., Meigs, D. D., & Hu, G. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105607 · Cited by 114 · cited 1×
“For instance, A β accumulation can disrupt the Sonic Hedgehog signaling pathway and other pathways that are guided by primary cilia, potentially leading to AD [49,130].”
Targeting Synaptic Plasticity in Experimental Models of Alzheimer’s Disease
Mango, D., Saidi, A., Cisale, G. Y., Feligioni, M., Corbo, M., & Nisticò, R. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00778 · Cited by 107 · cited 1×
“…specifically in the hippocampus, which is a common occurrence seen in AD, as well as the membrane potential in the axons of the optic nerve [73,78]. nNOS seems to affect neurovascular coupling, which connects brief neural activity to modifications in CBF, whereas eNOS tends to affect…”
Memantine nanoemulsion: a new approach to treat Alzheimer’s disease
Kaur, A., Nigam, K., Srivastava, S., Tyagi, A., & Dang, S. (2020) · Journal of Microencapsulation · doi:10.1080/02652048.2020.1756971 · Cited by 106 · cited 2×
“A different approach was taken with a nanoemulsion loaded with memantine for an intranasal delivery to circumvent the BBB [143].”
Ushio‐Fukai, M., Ash, D., Nagarkoti, S., de Chantemèle, E. J. B., Fulton, D. J., & Fukai, T. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8161 · Cited by 102 · cited 1×
“NO radical is one example of a reactive nitrogen species (RNS) and is synthesized by nitric oxide synthase (NOS) [68].”
Stereocilia morphogenesis and maintenance through regulation of actin stability
McGrath, J., Roy, P., & Perrin, B. J. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.08.017 · Cited by 101
Puthiyedth, N., Riveros, C., Berretta, R., & Moscato, P. (2016) · PLOS ONE · doi:10.1371/journal.pone.0152342 · Cited by 100 · cited 1×
“The hippocampus, a portion of the temporal lobe that is important in the formation of new memories, is an area of the brain that degenerates early in AD pathology [14].”
Cilia in the choroid plexus: their roles in hydrocephalus and beyond
Narita, K., & Takeda, S. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00039 · Cited by 99
Endothelial nitric oxide synthase: A potential therapeutic target for cerebrovascular diseases
Zhu, J., Song, W., Li, L., & Fan, X. (2016) · Molecular Brain · doi:10.1186/s13041-016-0211-9 · Cited by 96 · cited 1×
“On the other hand, restoration of endothelial NO signaling has been shown to mitigate these phenotypes across several experimental models [56,115,116], highlighting the therapeutic potential of restoring or enhancing endothelial NO signaling to stabilize the neurovascular unit, reduce amyloid…”
AI-driven fusion of multimodal data for Alzheimer’s disease biomarker assessment
Jasodanand, V. H., Kowshik, S. S., Puducheri, S., Romano, M. F., Xu, L., Au, R., & Kolachalama, V. B. (2025) · Nature Communications · doi:10.1038/s41467-025-62590-4 · Cited by 96 · cited 2×
“Some scientists are turning to machine learning models to predict individual-level A β and τ PET positivity status [136].”
Garcia, X., & Stein, F. (2006) · Seminars in Pediatric Infectious Diseases · doi:10.1053/j.spid.2006.04.002 · Cited by 95
Tsartsalis, S., Sleven, H., Fancy, N., Wessely, F., Smith, A. M., Willumsen, N., Cheung, T. K. D., Rokicki, M. J., Chau, V., Ifie, E., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46630-z · Cited by 95
Rani, V., Verma, R., Kumar, K., & Chawla, R. (2023) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2022.100149 · Cited by 93 · cited 2×
“Memory-impaired mice were also given various dosages of the memantine-loaded PLGA self-assembled scaffolds intrathecally and found a significant reduction in pro-inflammatory cytokines [142].”
Kamila, P., Kar, K., Chowdhury, S., Chakraborty, P., Dutta, R., S, S., Singh S, A., & Prajapati, B. G. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2025.05.005 · Cited by 90 · cited 1×
“…microglial overactivation and the nucleotide-binding domain, leucine-rich–containing family, pyrin domain–containing-3 (NLRP3) inflammasome, has gained recognition as a major driver of neuronal damage in AD, fueling a destructive cycle of reduced amyloid clearance and ongoing degeneration [9].”
Blood Pressure Variability and Progression of Clinical Alzheimer Disease
de Heus, R. A. A., Olde Rikkert, M. G. M., Tully, P. J., Lawlor, B. A., Claassen, J. A. H. R., & for the NILVAD Study Group (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13664 · Cited by 88 · cited 1×
“Higher blood pressure causes stiffening and remodeling of large arteries because of the increased mechanical stress placed on the arterial walls [89].”
Preis, L., Villringer, K., Brosseron, F., Düzel, E., Jessen, F., Petzold, G. C., Ramírez, A., Spottke, A. E., Fiebach, J. B., & Peters, O. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01529-1 · Cited by 88 · cited 2×
“The study showed higher K trans rates in the AD patients than those with NC or MCI, suggesting BBB disruption in the AD patients, but showed no differences in Q-Alb [120].”
Primary Cilia: Highly Sophisticated Biological Sensors
Abou Alaiwi, W. A., Lo, S. T., & Nauli, S. M. (2009) · Sensors · doi:10.3390/s90907003 · Cited by 82 · cited 1×
“Figure is adopted with permission from [21].”
Self-citationNeuronal and astrocytic primary cilia in the mature brain
Sterpka, A., & Chen, X. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.10.002 · Cited by 80 · cited 2×
“Glioblastomas are brain tumors that arise from the irregular proliferation of astrocytes and are highly related to malformed primary cilia [29].”
Identification of drugs that restore primary cilium expression in cancer cells
Khan, N. A., Willemarck, N., Talebi, A., Marchand, A., Binda, M. M., Dehairs, J., Rueda-Rincon, N., Daniels, V. W., Bagadi, M., Raj, D. B. T. G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7198 · Cited by 80 · cited 1×
“A few studies have identified various compounds and drugs that restore cilia length, including MI-181 in retinal pigment epithelial-1 cells, cevimeline in Tg737 Orpk/Orpk cells, and Clofibrate, Sirolimus, and Dexamethasone in various cancer cell types [52,131,132].”
Mapping of neuronal and glial primary cilia contactome and connectome in the human cerebral cortex
Wu, J. Y., Cho, S.-J., Descant, K., Li, P. H., Shapson-Coe, A., Januszewski, M., Berger, D. R., Meyer, C., Casingal, C., Huda, A., et al. (2024) · Neuron · doi:10.1016/j.neuron.2023.09.032 · Cited by 80 · cited 2×
“These neuronal cilia sense neuromodulators in the surrounding environment and influence neuronal functions by contacts it makes with synapses, axonal segments, and other cells [53].”
Non-Random Distribution and Sensory Functions of Primary Cilia in Vascular Smooth Muscle Cells
Lu, C. J., Du, H., Wu, J., Jansen, D. A., Jordan, K. L., Xu, N., Sieck, G. C., & Qian, Q. (2008) · Kidney and Blood Pressure Research · doi:10.1159/000132462 · Cited by 79
Dual role of nitric oxide in Alzheimer's disease
Azargoonjahromi, A. (2023) · Nitric Oxide · doi:10.1016/j.niox.2023.03.003 · Cited by 77 · cited 5×
“…of Ca 2+ and plays an important role in the regulation of neuroinflammation by allowing NO to function as a vasodilator as well as a stimulant in leukocyte adhesion to blood vessels in the endothelium [73]. eNOS is a non-soluble enzyme frequently located in the plasma or Golgi body membrane [71].”
InfluentialAmyloid precursor protein increases cortical neuron size in transgenic mice
Oh, E. S., Savonenko, A. V., King, J. F., Fangmark Tucker, S. M., Rudow, G. L., Xu, G., Borchelt, D. R., & Troncoso, J. C. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.12.024 · Cited by 75 · cited 1×
“APP moderates cell growth, motility, and survival, as well as neurite outgrowth and functions, but in the disease state, APP produces amyloidogenic fragments through differential cleavage by Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE-1) [11,12].”
Alzheimer’s Disease: Combination Therapies and Clinical Trials for Combination Therapy Development
Cummings, J. L., Osse, A. M. L., Kinney, J. W., Cammann, D., & Chen, J. (2024) · CNS Drugs · doi:10.1007/s40263-024-01103-1 · Cited by 75
Endothelial Nitric Oxide Synthase–Deficient Mice
Liao, F., Lin, G., Chen, X., Chen, L., Zheng, W., Raghow, R., Zhou, F.-M., Shih, A. Y., & Tan, X.-L. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.02.022 · Cited by 74 · cited 2×
“Emerging preclinical and early clinical evidence implicates eNOS deficits as a critical mechanistic link between neurovascular unit (NVU) dysfunction, BBB breakdown, and cognitive decline [112,113].”
Emerging Roles of Endothelial Nitric Oxide in Preservation of Cognitive Health
Katusic, Z. S., d’Uscio, L. V., & He, T. (2023) · Stroke · doi:10.1161/strokeaha.122.041444 · Cited by 73 · cited 2×
“…primary cilia as shear-stress mechanosensors that regulate NO bioavailability, barrier integrity, and neurovascular coupling; work in AD models and patient-relevant systems associates endothelial cilia dysfunction with early neurovascular decoupling and cerebrovascular instability [52,55,56].”
Role of endothelial primary cilia as fluid mechanosensors on vascular health
Luu, V. Z., Chowdhury, B., Al-Omran, M., Hess, D. A., & Verma, S. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.06.818 · Cited by 72
Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure
Vorobyeva, A. G., & Saunders, A. J. (2018) · Cilia · doi:10.1186/s13630-018-0059-y · Cited by 67
An, L., Shen, Y., Chopp, M., Zacharek, A., Venkat, P., Chen, Z., Li, W., Yu, Q., Landschoot‐Ward, J., & Chen, J. (2021) · Aging and Disease · doi:10.14336/ad.2020.0523 · Cited by 67 · cited 1×
“Emerging preclinical and early clinical evidence implicates eNOS deficits as a critical mechanistic link between neurovascular unit (NVU) dysfunction, BBB breakdown, and cognitive decline [112,113].”
A review of the mechanisms underlying selected comorbidities in Alzheimer’s disease
Maciejewska, K., Czarnecka, K., & Szymański, P. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00293-5 · Cited by 64 · cited 2×
“Insulin resistance and a high level of glucose factor into increased morbidity [85].”
Endothelial nitric oxide synthase-derived nitric oxide in the regulation of metabolism
Tenopoulou, M., & Doulias, P.-T. (2020) · F1000Research · doi:10.12688/f1000research.19998.1 · Cited by 63 · cited 2×
“It can be found both pre-and postsynaptically within the cytoplasm and membrane of each subpopulation in each major neuron type within their ventral cochlear nucleus [76]. nNOS is also found within smooth muscle and within the cells of the central and peripheral nervous systems [74].”
Hypertension and Alzheimer’s disease pathology at autopsy: A systematic review
Abdulrahman, H., van Dalen, J. W., den Brok, M., Latimer, C. S., Larson, E. B., & Richard, E. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12707 · Cited by 63 · cited 1×
“A systematic review of four studies showed a direct association between hypertension and AD neuropathic change [87].”
Role of Primary Cilia in Bone and Cartilage
Chinipardaz, Z., Liu, M., Graves, D. T., & Yang, S. (2021) · Journal of Dental Research · doi:10.1177/00220345211046606 · Cited by 63
Miners, J. S., Hulle, C. V., Ince, S., Jonaitis, E., Okonkwo, O., Bendlin, B. B., Johnson, S. C., Carlsson, C. M., Asthana, S., Love, S., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-023-02706-w · Cited by 61 · cited 1×
“One analysis looked at ANGPT-2 in three cohorts of AD patients and healthy patients and found elevated levels of ANGPT-2 in patients with AD, as well as positive correlation of CSF ANGPT-2 to Q-Alb in cohort iii [122].”
Luo, Q., Yang, J., Yang, M., Wang, Y., Liu, Y., Liu, J., Kalvakolanu, D. V., Cong, X., Zhang, J., Zhang, L., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101457 · Cited by 61 · cited 1×
“This leads to limits in the delivery of effective drugs and reduces therapeutic efficiency [141].”
Targeting the M1 muscarinic acetylcholine receptor in Alzheimer’s disease
Dwomoh, L., Tejeda, G. S., & Tobin, A. B. (2022) · Neuronal Signaling · doi:10.1042/ns20210004 · Cited by 60 · cited 6×
“However, the utility of AChEIs is limited by adverse effects stemming from the nonspecific up-regulation of cholinergic signaling across the whole body [61].”
InfluentialAdvancing combination therapy for Alzheimer's disease
Salloway, S. P., Sevingy, J., Budur, K., Pederson, J. T., DeMattos, R. B., Von Rosenstiel, P., Paez, A., Evans, R., Weber, C. J., Hendrix, J. A., et al. (2020) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12073 · Cited by 57 · cited 1×
“While this method shows promise, experts in the field recognize that combination approaches present challenges in clinical trial design, regulatory requirements, and non-clinical model limitations [138].”
Li, M., Li, Y., Zuo, L., Hu, W., & Jiang, T. (2021) · BMC Neurology · doi:10.1186/s12883-021-02189-6 · Cited by 56 · cited 1×
“One study used this technique to determine BBB leakage in patients with vascular mild cognitive impairment and found a higher leakage rate in various parts of the brain compared to age-matched controls [119].”
Nitric oxide/cGMP/CREB pathway and amyloid-beta crosstalk: From physiology to Alzheimer’s disease
Tropea, M. R., Gulisano, W., Vacanti, V., Arancio, O., Puzzo, D., & Palmeri, A. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.11.022 · Cited by 55 · cited 5×
“Both the fibrillar and oligomeric forms of A β suppressed the NO-mediated activation of soluble guanylyl cyclase, causing a decrease in cGMP production [69].”
InfluentialPrimary cilia mediate Klf2-dependant Notch activation in regenerating heart
Li, X., Lu, Q., Peng, Y., Geng, F., Shao, X., Zhou, H., Cao, Y., & Zhang, R. (2020) · Protein & Cell · doi:10.1007/s13238-020-00695-w · Cited by 55
The Kinocilia of Cochlear Hair Cells: Structures, Functions, and Diseases
Wang, D., & Zhou, J. Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.715037 · Cited by 53
French, S. R., Meyer, B. P., Arias, J. C., Levendovszky, S. R., & Weinkauf, C. C. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70104 · Cited by 53 · cited 8×
“In healthy patients, protein levels of albumin are 100 to 200 times higher in the blood than in the CSF, as albumin originates in the blood [118].”
InfluentialPartial loss of endothelial nitric oxide leads to increased cerebrovascular beta amyloid
Austin, S. A., & Katusic, Z. S. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18822474 · Cited by 52 · cited 1×
“One study showed that a decrease in the availability of eNOS leads to a higher cerebrovascular concentration of A β [99].”
Primary Cilia and Calcium Signaling Interactions
Saternos, H. C., Ley, S. T., & AbouAlaiwi, W. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197109 · Cited by 48 · cited 1×
“The ciliary membrane has a variety of localized receptors and channels that make its predominant function the detection, transmission, and translation of external mechanical or chemical stimuli [44].”
Self-citationIschemia as a common trigger for Alzheimer’s disease
Elman-Shina, K., & Efrati, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1012779 · Cited by 48 · cited 1×
“These conditions are a common trigger for AD development when the NOS output seems to have reached its maximum threshold [73,80].”
Venkatesh, D. (2017) · Journal of Oral and Maxillofacial Pathology · doi:10.4103/jomfp.jomfp_48_17 · Cited by 42 · cited 1×
“Cilia are hair-like structures that project from the surface of various cell types in the body, including stem, neuronal, endothelial, and epithelial [22].”
Wang, L., Guo, Q., Acharya, S., Zheng, X., Huynh, V., Whitmore, B., Yimit, A., Malhotra, M., Chatterji, S., Rosin, N., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01726-z · Cited by 33
(2015) · doi:10.15586/codon.pkd.2015 · Cited by 29
Sonic hedgehog signalling pathway contributes in age-related disorders and Alzheimer’s disease
Parashar, A., jha, D., Mehta, V., Chauhan, B., Ghosh, P., Deb, P. K., Jaiswal, M., & Prajapati, S. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102271 · Cited by 28 · cited 1×
“In this context, primary cilia have emerged as important signaling hubs, and dysregulation of pathways coordinated through them, such as Sonic hedgehog (Shh), may contribute to impaired neuronal function in AD [20].”
Liu, X., Pacwa, A., Bresciani, G., Swierczynska, M., Dorecka, M., & Smędowski, A. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00875-y · Cited by 27
Blood pressure variability and plasma Alzheimer’s disease biomarkers in older adults
Sible, I. J., Yew, B., Jang, J. Y., Alitin, J. P. M., Li, Y., Gaubert, A., Nguyen, A., Dutt, S., Blanken, A. E., Ho, J. K., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-20627-4 · Cited by 26
Ciliary IFT80 regulates dental pulp stem cells differentiation by FGF/FGFR1 and Hh/BMP2 signaling
Yuan, X., Liu, M., Cao, X., & Yang, S. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.27231 · Cited by 26
Saito, M., Otsu, W., Miyadera, K., & Nishimura, Y. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1232188 · Cited by 23 · cited 1×
“Therapeutic approaches aim to restore or enhance ciliary function and/or structure, modulate the cilia-associated components, and target cilia-related downstream mechanisms to help end progression or cure the disease [129].”
Szidonya, L., & Nickerson, J. P. (2023) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2023.01.009 · Cited by 21 · cited 1×
“Cerebral amyloid angiopathy (CAA) involves the cerebrovascular deposition of A β in the cortical and leptomeningeal blood vessels [97].”
Signaling interplay between primary cilia and nitric oxide: A mini review
Saternos, H. C., & AbouAlaiwi, W. A. (2018) · Nitric Oxide · doi:10.1016/j.niox.2018.08.003 · Cited by 21 · cited 4×
“Each isoform possesses its own function, with the ability to work independently and together within various systems. iNOS is a soluble enzyme that is able to exist in the cytosol [71].”
InfluentialSelf-citationA review of proposed mechanisms for neurodegenerative disease
Kelser, B. M., Teichner, E. M., Subtirelu, R. C., & Hoss, K. N. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1370580 · Cited by 20 · cited 1×
“While awaiting definitive evidence, many researchers currently consider both mechanisms as coexisting factors in disease progression [6].”
Primary cilia-mediated regulation of microglial secretion in Alzheimer’s disease
Yeo, S., Jang, J., Jung, H. J., Lee, H., & Choe, Y. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1250335 · Cited by 18 · cited 1×
“This inflammatory milieu impairs the function of primary cilia on endothelial and neuronal cells, disrupting key signaling pathways such as Sonic hedgehog and Wnt that are essential for vascular stability and neuronal communication [125,126].”
Impairment of ciliary dynamics in an APP knock-in mouse model of Alzheimer’s disease
Kobayashi, Y., Kohbuchi, S., Koganezawa, N., Sekino, Y., Shirao, T., Saido, T. C., Saito, T., & Saito, Y. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.04.050 · Cited by 18
Bae, J.-E., Jang, S., Kim, J. B., Hyung, H., Park, N. Y., Kim, Y. H., Ys, K., Kim, S. H., Ha, J. M., Oh, G. S., et al. (2023) · Molecular Brain · doi:10.1186/s13041-023-01029-7 · Cited by 17 · cited 1×
“Consequently, a growing body of evidence highlights a complex interplay between primary cilia and mitochondrial function [133].”
Primary cilia in hard tissue development and diseases
Li, S., Zhang, H., & Sun, Y. (2021) · Frontiers of Medicine · doi:10.1007/s11684-021-0829-6 · Cited by 15
Liu, C., Chen, X., Yang, S., Wang, X., Sun, P., Wang, J., & Zhu, G. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.115116 · Cited by 15 · cited 1×
“…develop early hypoperfusion, progressive BBB hyperpermeability, white-matter injury, microinfarcts, and age-dependent memory impairments and show greater BBB disruption under stressors such as hypoxia or chronic hypoperfusion, with worse cognitive outcomes when eNOS is reduced or absent [112,114].”
Hockley, A. D., Berger, J. I., Smith, P. A., Palmer, A. R., & Wallace, M. N. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14572 · Cited by 14 · cited 1×
“It can be found both pre-and postsynaptically within the cytoplasm and membrane of each subpopulation in each major neuron type within their ventral cochlear nucleus [76]. nNOS is also found within smooth muscle and within the cells of the central and peripheral nervous systems [74].”
Lee, S. G., Lee, S., Baek, J., Yoon, J., & Lee, H. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.04.030 · Cited by 14
(2024) · Vitamins and Hormones · doi:10.1016/bs.vh.2024.04.006 · Cited by 13 · cited 1×
“This inflammatory milieu impairs the function of primary cilia on endothelial and neuronal cells, disrupting key signaling pathways such as Sonic hedgehog and Wnt that are essential for vascular stability and neuronal communication [125,126].”
The primary cilia are associated with the axon initial segment in neurons
Wang, H., Li, Y., Li, X., Sun, Z., Yu, F., Pashang, A., Kulasiri, D., Li, H. W., Chen, H., Hou, H., et al. (2025) · Advanced Science · doi:10.1002/advs.202407405 · Cited by 13 · cited 1×
“In AD models, ciliary signaling and dynamics are perturbed and linked to defects in dendritic integration, connectivity, and memory function [54].”
Saternos, H. C., Forero, K. V., Meqdad, M. A., Buqaileh, R., Sunderman, C. L., Gallagher, G., Messer, W. S., Mohieldin, A. M., Mucci, C. A., Kumariya, S., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-87212-3 · Cited by 12 · cited 9×
“A few studies have identified various compounds and drugs that restore cilia length, including MI-181 in retinal pigment epithelial-1 cells, cevimeline in Tg737 Orpk/Orpk cells, and Clofibrate, Sirolimus, and Dexamethasone in various cancer cell types [52,131,132].”
InfluentialSelf-citationOlfactory cilia, regulation and control of olfaction
Takeuchi, H. T. (2024) · Physiological Reports · doi:10.14814/phy2.70057 · Cited by 12
Osset-Malla, M., Martínez-Velasco, A., Sánchez-Benavides, G., Buongiorno, M., de la Sierra, A., Shekari, M., Minguillon, C., Kollmorgen, G., Quijano-Rubio, C., Zetterberg, H., et al. (2025) · The Journal of Prevention of Alzheimer's Disease · doi:10.1016/j.tjpad.2025.100304 · Cited by 8 · cited 3×
“It also showed a negative association between diastolic blood pressure and CSF levels of A β 42 and p-tau181 but these associations went away after adjusting for CSF AB 40 [91].”
InfluentialChanges of the Primary Cilia in Alzheimer's Disease Pathogenesis
Guo, A., Wang, H., Zhang, Y., & Huang, H. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70125 · Cited by 7 · cited 3×
“The shortening of cilia can impair their ability to sense and regulate external signals, leading to the promotion of AD [47].”
InfluentialMI-181 Modulates Cilia Length and Restores Cilia Length in Cells with Defective Shortened Cilia
Gholkar, A. A., Gimeno, T. V., Edgemon, J. E., Sim, M., & Torres, J. Z. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.4c00186 · Cited by 6 · cited 1×
“A few studies have identified various compounds and drugs that restore cilia length, including MI-181 in retinal pigment epithelial-1 cells, cevimeline in Tg737 Orpk/Orpk cells, and Clofibrate, Sirolimus, and Dexamethasone in various cancer cell types [52,131,132].”
Implications of Dysfunction of Mechanosensory Cilia in Polycystic Kidney Disease
Saternos, H. C., & AbouAlaiwi, W. A. (2015) · Codon Publications eBooks · doi:10.15586/codon.pkd.2015.ch16 · Cited by 5
Self-citationSunderman, C., Forero, K., Buqaileh, R., & Aboualaiwi, W. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.089289 · Cited by 1
Self-citation
Cited by
Roles of primary cilia in cardiovascular diseases: mechanisms and therapeutic prospects
Yang, Z., 唐永松, Guan, B., Zhao, C., Shang, Y., Xiong, M., Xu, M., Liu, Y., Qin, Z., Yang, Z., et al. (2026) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2026.121878
Metadata
- Authors
- Sunderman, C. L., Forero, K. V., Alorjani, Q., Buqaileh, R., Gallagher, G. M., Ventresca, S. M., Messer, W. S., & AbouAlaiwi, W. A.
- Affiliations
- University of Toledo (US)
- Corresponding author
- AbouAlaiwi, Wissam A.
- Venue
- Brain Sciences
- Publisher
- MDPI AG
- Published
- 2025-09-17
- Volume
- 15
- Issue
- 9
- Pages
- 1004
- ISSN
- 2076-3425 (ISSN-L)
- PMC
- PMC12468187
- OpenAlex
- W4414298326
- Cited by
- 1
- References
- 142
- Citations by year
- 2026: 1
- FWCI
- 0.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Brain Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of Toledo Office of Research and Sponsored Programs (AARGD-NTF-22-972749, 1R03AG080418-01, 5R25HL105446-12)
- Alzheimer’s Association (AARGD-NTF-22-972749, 1R03AG080418-01, 5R25HL105446-12)
- NIA (AARGD-NTF-22-972749, 1R03AG080418-01, 5R25HL105446-12)
- NHLBI (AARGD-NTF-22-972749, 1R03AG080418-01, 5R25HL105446-12)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- Alzheimer's disease, primary cilia, cardiovascular risk factors, nitric oxide signaling, vascular pathology, cognitive decline, amyloid plaques, neurofibrillary tangles, therapeutic target
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-28, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-28 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.